Literature DB >> 26885229

Inhibition of adriamycin-induced nephropathy in rats by herbs based kangshenoral solution.

Jingsheng Zhao1, Xinwei Lin1, Xueqing Xiao2, Jun Yang1, Hong Liu3, Weiguo Yi4, Zhengchen Zhang3, Xinkuan Zhang5.   

Abstract

The Chronic kidney disease (CKD) is characterized by the progressive loss in renal function over a period. The progression of CKD will finally result the End Stage Renal Disease (ESRD) Symptoms which needs permanent renal replacement therapies. Therefore, control the progression of CKD is necessary. In this study, based on the theory of Traditional Chinese Medicine and the Traditional Chinese Herbology, we developed the Kangshen Oral Solution based ona combination of different herbs for extraction. By utilizing adriamycin (ARD)-induced chronic renal failure in rats as the CKD model, our results demonstrated thatadministration of the Kangshen Oral Solution reduced the kidney disease induced weight loss in rats. The Kangshen Oral Solution could also relieve the proteinuria and kidney index induced by ARD which indicated the partially restoration of the kidney function. The improved kidney function was further supported by biochemical tests for blood total protein level, albumin level as well as cholesterol, triglycerides and Creatinine. Moreover, the histology examination also confirmed the ARD induced pathological changes in kidney was relieved by Kangshen Oral Solution. Taken together, these findings suggested Kangshen Oral solution could reduce ARD-induced nephropathy in rats model and may be employed as an alternative treatment for CKD patients.

Entities:  

Keywords:  Chinese traditional medicine; Chronic kidney disease (CKD); adriamycin-induced nephropathy; herbology

Year:  2015        PMID: 26885229      PMCID: PMC4730015     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  24 in total

Review 1.  Herbal treatment for renal diseases.

Authors:  A Peng; Y Gu; S Y Lin
Journal:  Ann Acad Med Singapore       Date:  2005-01       Impact factor: 2.473

Review 2.  Astragalus (a traditional Chinese medicine) for treating chronic kidney disease.

Authors:  Hong Wei Zhang; Zhi Xiu Lin; Chuanshan Xu; Connie Leung; Lai Sum Chan
Journal:  Cochrane Database Syst Rev       Date:  2014-10-22

3.  [Effect of Saiboku-to, a blended Chinese traditional medicine, on Type I hypersensitivity reactions, particularly on experimentally-caused asthma].

Authors:  T Nishiyori; H Tsuchiya; N Inagaki; H Nagai; A Koda
Journal:  Nihon Yakurigaku Zasshi       Date:  1985-01

4.  Pycnogenol as an adjunct in the management of childhood asthma.

Authors:  Benjamin H S Lau; Sharon K Riesen; Kim P Truong; Esther W Lau; Peter Rohdewald; Ray A Barreta
Journal:  J Asthma       Date:  2004       Impact factor: 2.515

Review 5.  Herbs or natural substances as complementary therapies for chronic kidney disease: ideas for future studies.

Authors:  Ken Wojcikowski; David W Johnson; Glenda Gobe
Journal:  J Lab Clin Med       Date:  2006-04

Review 6.  Increased mortality in chronic kidney disease: a call to action.

Authors:  Mark A Perazella; Samina Khan
Journal:  Am J Med Sci       Date:  2006-03       Impact factor: 2.378

7.  A strategy for discovering biologically active compounds with high probability in traditional Chinese herb remedies: an application of saiboku-to in bronchial asthma.

Authors:  M Homma; K Oka; T Yamada; T Niitsuma; H Ihto; N Takahashi
Journal:  Anal Biochem       Date:  1992-04       Impact factor: 3.365

8.  Pressor mechanisms in adriamycin-induced nephropathy with hypertension in rats.

Authors:  R Franco; A Gut; A Ferrari-Spadotto; J Georgette; I Gavras; H Gavras
Journal:  Hypertension       Date:  1994-01       Impact factor: 10.190

9.  Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease.

Authors:  S Okuda; Y Oh; H Tsuruda; K Onoyama; S Fujimi; M Fujishima
Journal:  Kidney Int       Date:  1986-02       Impact factor: 10.612

10.  Pycnogenol((R)) in the Management of Asthma.

Authors:  Saeed Hosseini; S. Pishnamazi; S. M.H. Sadrzadeh; F. Farid; R. Farid; Ronald R. Watson
Journal:  J Med Food       Date:  2001       Impact factor: 2.786

View more
  1 in total

1.  Integrated Metabolomics and Network Pharmacology to Establish the Action Mechanism of Qingrekasen Granule for Treating Nephrotic Syndrome.

Authors:  Yanfen Duan; Dongning Zhang; Yan Ye; Sili Zheng; Ping Huang; Fengyun Zhang; Guoyan Mo; Fang Huang; Qiang Yin; Jingjing Li; Lintao Han
Journal:  Front Pharmacol       Date:  2021-12-06       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.